Novo Nordisk Optimization of Medical-Product Supply Chain in Baltic Region

01
01 / 14

TGS Baltic advised Novo Nordisk on the reorganization of its supply chain for medicinal products in the Baltic States, and prepared the relevant documentation. The firm is Novo Nordisk's main legal advisor in the Baltic States. We advise the client on diverse medicine and pharmaceuticals issues, and represent it in relationships with the Ministry of Health, the State Medicines Control Agency, the State Patients Fund and other authorities.

 Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.